What is fairly valued jdp?
fusion is valued at 845m US for an asset that is maybe 1-2 yrs ahead of cu6 in the clinical development timeframe for their mcrpc indication. But cu6 has other assets that are further along for imaging.
tlx jumped to 1.8b around the time they started getting revenue for their imaging asset. How much of the jump is based off their approved product? Just before approval, I think they were valued at around 700-900m AU, but they also had manufacturing facilities.
CU6 - ASX Charts, page-171
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.09 |
Change
-0.210(4.88%) |
Mkt cap ! $1.272B | |||
| Open | High | Low | Value | Volume |
| $4.30 | $4.30 | $4.08 | $3.493M | 835.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7459 | $4.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.12 | 9361 | 1 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.10 |
Change
-0.210 ( 4.15 %) |
||||
| Open | High | Low | Volume | ||
| $4.17 | $4.29 | $4.08 | 50363 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| CU6 (ASX) Chart |